Connect with us

Health

What have we learned about accelerating drug development from Covid-19? – MedCity News

This pandemic has shown that collaboration, biosimulation and decentralized trials, and active preparedness programs lead to…

Published

on

Article feature image

In response to Covid-19, the global drug development community has moved faster and further than ever before. But what have we learned from meeting this emergency? Players throughout the ecosystem, from drug developers to regulators, are considering how…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending